Abstract
Adults living with congenital heart disease (CHD) now outnumber children with the disease. Thanks to medical advances over the past 75 years, many of these fatal childhood heart problems have changed to chronic medical conditions. As the population of adults with CHD increases, they will require increasingly complex medical, surgical and catheter-based therapies. In addition, social burdens including education, employment and insurability, which increase the societal costs of adult CHD, are now being recognized for adults living with CHD. This review summarizes the available literature on the economics of adult CHD.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 85-96 |
| Number of pages | 12 |
| Journal | Expert Review of Pharmacoeconomics and Outcomes Research |
| Volume | 16 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2 2016 |
Fingerprint
Keywords
- Adult congenital heart disease
- atrial septal defects
- chronic disease
- economics
- healthcare resource utilization
- Hypoplastic left heart syndrome
- tetralogy of Fallot
ASJC Scopus subject areas
- Pharmacology (medical)
- Health Policy
Cite this
A review of the economics of adult congenital heart disease. / Seckeler, Michael D.; Thomas, Ian D.; Andrews, Jennifer; Joiner, Keith A; Klewer, Scott E.
In: Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 16, No. 1, 02.01.2016, p. 85-96.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - A review of the economics of adult congenital heart disease
AU - Seckeler, Michael D.
AU - Thomas, Ian D.
AU - Andrews, Jennifer
AU - Joiner, Keith A
AU - Klewer, Scott E
PY - 2016/1/2
Y1 - 2016/1/2
N2 - Adults living with congenital heart disease (CHD) now outnumber children with the disease. Thanks to medical advances over the past 75 years, many of these fatal childhood heart problems have changed to chronic medical conditions. As the population of adults with CHD increases, they will require increasingly complex medical, surgical and catheter-based therapies. In addition, social burdens including education, employment and insurability, which increase the societal costs of adult CHD, are now being recognized for adults living with CHD. This review summarizes the available literature on the economics of adult CHD.
AB - Adults living with congenital heart disease (CHD) now outnumber children with the disease. Thanks to medical advances over the past 75 years, many of these fatal childhood heart problems have changed to chronic medical conditions. As the population of adults with CHD increases, they will require increasingly complex medical, surgical and catheter-based therapies. In addition, social burdens including education, employment and insurability, which increase the societal costs of adult CHD, are now being recognized for adults living with CHD. This review summarizes the available literature on the economics of adult CHD.
KW - Adult congenital heart disease
KW - atrial septal defects
KW - chronic disease
KW - economics
KW - healthcare resource utilization
KW - Hypoplastic left heart syndrome
KW - tetralogy of Fallot
UR - http://www.scopus.com/inward/record.url?scp=84958166029&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84958166029&partnerID=8YFLogxK
U2 - 10.1586/14737167.2016.1140575
DO - 10.1586/14737167.2016.1140575
M3 - Article
C2 - 26765559
AN - SCOPUS:84958166029
VL - 16
SP - 85
EP - 96
JO - Expert Review of Pharmacoeconomics and Outcomes Research
JF - Expert Review of Pharmacoeconomics and Outcomes Research
SN - 1473-7167
IS - 1
ER -